Erik Stomrud

knuten till universitetet, Medicine doktor, Läkare, Medicine Doktor, Läkarexamen
Fler filtreringsmöjligheter
  1. 2021
  2. Health utility in preclinical and prodromal Alzheimer's disease for establishing the value of new disease-modifying treatments—EQ-5D data from the Swedish BioFINDER study

    Anders Gustavsson, Lars Lau Raket, Mathias Lilja, Loes Rutten-Jacobs, Hanna Fues Wahl, Marloes Bagijn, Erik Stomrud, Oskar Hansson & Sebastian Palmqvist, 2021 maj 13, I: Alzheimer's and Dementia.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau

    Niklas Mattsson-Carlgren, Shorena Janelidze, Randall J. Bateman, Ruben Smith, Erik Stomrud, Geidy E. Serrano, Eric M. Reiman, Sebastian Palmqvist, Jeffrey L. Dage, Thomas G. Beach & Oskar Hansson, 2021 maj 1, I: EMBO Molecular Medicine.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Alzheimer’s disease in primary care: new tools for improved and simplified diagnostics

    Henrik Zetterberg & Erik Stomrud, 2021 feb 6, I: Journal of Internal Medicine.

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  5. Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE ε4, sex and age

    Scott Ayton, Shorena Janelidze, Blaine Roberts, Sebastian Palmqvist, Pawel Kalinowski, Ibrahima Diouf, Abdel A. Belaidi, Erik Stomrud, Ashley I. Bush & Oskar Hansson, 2021, I: Progress in Neurobiology. 198, 101904.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p-tau

    Shorena Janelidze, Sebastian Palmqvist, Antoine Leuzy, Erik Stomrud, Inge M.W. Verberk, Henrik Zetterberg, Nicholas J. Ashton, Pedro Pesini, Leticia Sarasa, José Antonio Allué, Charlotte E. Teunissen, Jeffrey L. Dage, Kaj Blennow, Niklas Mattsson-Carlgren & Oskar Hansson, 2021, I: Alzheimer's and Dementia.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. General practitioners’ attitude toward early and pre-dementia diagnosis of ad in five European countries—a mopead project survey

    Lena Sannemann, Theresa Müller, Lisa Waterink, Marissa Zwan, Anders Wimo, Erik Stomrud, Susana Pinó, Jordi Arrufat, Octavio Rodríguez-Gomez, Alba Benaque, Jaka Bon, Daniel Ferreira, Gunilla Johansson, Amanda Dron, Annette Dumas, Jean Georges, Milica G. Kramberger, Pieter Jelle Visser, Bengt Winblad, Laura Campo & 3 andra, Mercè Boada, Frank Jessen & MOPEAD consortium MOPEAD consortium, 2021, I: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 13, 1, e12130.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease

    Ellen Singleton, Oskar Hansson, Yolande A.L. Pijnenburg, Renaud La Joie, William G. Mantyh, Pontus Tideman, Erik Stomrud, Antoine Leuzy, Maurits Johansson, Olof Strandberg, Ruben Smith, Evi Berendrecht, Bruce L. Miller, Leonardo Iaccarino, Lauren Edwards, Amelia Strom, Emma E. Wolters, Emma Coomans, Denise Visser, Sandeep S.V. Golla & 9 andra, Hayel Tuncel, Femke Bouwman, John Cornelis Van Swieten, Janne M. Papma, Bart Van Berckel, Philip Scheltens, Anke A. Dijkstra, Gil D. Rabinovici & Rik Ossenkoppele, 2021, (Accepted/In press) I: Journal of Neurology, Neurosurgery and Psychiatry.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease

    Sara Hall, Shorena Janelidze, Elisabet Londos, Antoine Leuzy, Erik Stomrud, Jeffrey L. Dage & Oskar Hansson, 2021, I: Movement Disorders. 36, 3, s. 767-771

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures

    Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2021, I: Nature Medicine.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease

    Joana B. Pereira, Shorena Janelidze, Rik Ossenkoppele, Hlin Kvartsberg, Ann Brinkmalm, Niklas Mattsson-Carlgren, Erik Stomrud, Ruben Smith, Henrik Zetterberg, Kaj Blennow & Oskar Hansson, 2021, I: Brain : a journal of neurology. 144, 1, s. 310-324 15 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. 2020
  13. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

    Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz, Henrik Zetterberg, Francisco Lopera, Erik Stomrud, Yi Su, Yinghua Chen, Geidy E. Serrano, Antoine Leuzy, Niklas Mattsson-Carlgren, Olof Strandberg, Ruben Smith, Andres Villegas, Diego Sepulveda-Falla, Xiyun Chai, Nicholas K. Proctor, Thomas G. Beach, Kaj Blennow, Jeffrey L. Dage & 2 andra, Eric M. Reiman & Oskar Hansson, 2020 aug 25, I: JAMA - Journal of the American Medical Association. 324, 8, s. 772-781 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease

    Joana B. Pereira, Sara Hall, Mattis Jalakas, Michel J. Grothe, Olof Strandberg, Erik Stomrud, Eric Westman, Danielle van Westen & Oskar Hansson, 2020 jun, I: Neurobiology of Disease. 139, 104831.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Relationship between cortical iron and tau aggregation in Alzheimer's disease

    Nicola Spotorno, Julio Acosta-Cabronero, Erik Stomrud, Björn Lampinen, Olof T. Strandberg, Danielle van Westen & Oskar Hansson, 2020 maj, I: Brain : a journal of neurology. 143, 5, s. 1341-1349 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

    Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Ruben Smith, Thomas G. Beach, Geidy E. Serrano, Xiyun Chai, Nicholas K. Proctor, Udo Eichenlaub, Henrik Zetterberg, Kaj Blennow, Eric M. Reiman, Erik Stomrud, Jeffrey L. Dage & Oskar Hansson, 2020 mar 2, I: Nature Medicine. 26, 3, s. 379-386 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Apathy and anxiety are early markers of Alzheimer's disease

    Maurits Johansson, Erik Stomrud, Olof Lindberg, Eric Westman, Per Mårten Johansson, Danielle van Westen, Niklas Mattsson & Oskar Hansson, 2020, I: Neurobiology of Aging. 85, s. 74-82

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease

    Niklas Mattsson-Carlgren, Emelie Andersson, Shorena Janelidze, Rik Ossenkoppele, Philip Insel, Olof Strandberg, Henrik Zetterberg, Howard J. Rosen, Gil Rabinovici, Xiyun Chai, Kaj Blennow, Jeffrey L. Dage, Erik Stomrud, Ruben Smith, Sebastian Palmqvist & Oskar Hansson, 2020, I: Science Advances. 6, 16, eaaz2387.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

    Thomas K. Karikari, Tharick A. Pascoal, Nicholas J. Ashton, Shorena Janelidze, Andréa Lessa Benedet, Juan Lantero Rodriguez, Mira Chamoun, Melissa Savard, Min Su Kang, Joseph Therriault, Michael Schöll, Gassan Massarweh, Jean Paul Soucy, Kina Höglund, Gunnar Brinkmalm, Niklas Mattsson, Sebastian Palmqvist, Serge Gauthier, Erik Stomrud, Henrik Zetterberg & 3 andra, Oskar Hansson, Pedro Rosa-Neto & Kaj Blennow, 2020, I: The Lancet Neurology. 19, 5, s. 422-433 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. CDH6 and HAGH protein levels in plasma associate with Alzheimer’s disease in APOE ε4 carriers

    Shahzad Ahmad, Marta del Campo Milan, Oskar Hansson, Ayse Demirkan, Ruiz Agustin, Maria E. Sáez, Nikolaos Giagtzoglou, Alfredo Cabrera-Socorro, Margot H.M. Bakker, Alfredo Ramirez, Thomas Hankemeier, Erik Stomrud, Niklas Mattsson-Carlgren, Philip Scheltens, Wiesje M. van der Flier, M. Arfan Ikram, Anders Malarstig, Charlotte E. Teunissen, Najaf Amin & Cornelia M. van Duijn, 2020, I: Scientific Reports. 10, 1, 8233.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease

    Shorena Janelidze, Erik Stomrud, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson, David C. Airey, Nicholas K. Proctor, Xiyun Chai, Sergey Shcherbinin, John R. Sims, Gallen Triana-Baltzer, Clara Theunis, Randy Slemmon, Marc Mercken, Hartmuth Kolb, Jeffrey L. Dage & Oskar Hansson, 2020, I: Nature Communications. 11, 1, 1683.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ load

    Antoine Leuzy, Johan Lilja, Christopher J. Buckley, Rik Ossenkoppele, Sebastian Palmqvist, Mark Battle, Gill Farrar, Dietmar R. Thal, Shorena Janelidze, Erik Stomrud, Olof Strandberg, Ruben Smith & Oskar Hansson, 2020, I: Neurology. 95, 21, s. e2834-e2844

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease

    Niklas Mattsson-Carlgren, Shorena Janelidze, Sebastian Palmqvist, Nicholas Cullen, Anna L. Svenningsson, Olof Strandberg, David Mengel, Dominic M. Walsh, Erik Stomrud, Jeffrey L. Dage & Oskar Hansson, 2020, I: Brain : a journal of neurology. 143, 11, s. 3234-3241 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Pre-analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF

    Oskar Hansson, Sandra Rutz, Henrik Zetterberg, Ekaterina Bauer, Teresa Hähl, Ekaterina Manuilova, Mehmet Can Mert, Simone Wahl, Kaj Blennow & Erik Stomrud, 2020, I: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 12, 1, e12137.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Quantification of total apolipoprotein e and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases

    K. Minta, G. Brinkmalm, S. Janelidze, S. Sjödin, E. Portelius, E. Stomrud, H. Zetterberg, K. Blennow, O. Hansson & U. Andreasson, 2020, I: Alzheimer's Research and Therapy. 12, 1, 19.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. 2019
  27. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

    Sebastian Palmqvist, Philip S. Insel, Erik Stomrud, Shorena Janelidze, Henrik Zetterberg, Britta Brix, Udo Eichenlaub, Jeffrey L. Dage, Xiyun Chai, Kaj Blennow, Niklas Mattsson & Oskar Hansson, 2019 dec 1, I: EMBO Molecular Medicine. 11, 12, e11170.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Determining clinically meaningful decline in preclinical Alzheimer disease

    Philip S. Insel, Michael Weiner, R. Scott Mackin, Elizabeth Mormino, Yen Ying Lim, Erik Stomrud, Sebastian Palmqvist, Colin L. Masters, Paul T. Maruff, Oskar Hansson & Niklas Mattsson, 2019 jul 23, I: Neurology. 93, 4, s. e322-e333

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Towards a unified protocol for handling of CSF before β-amyloid measurements

    Shorena Janelidze, Erik Stomrud, Britta Brix & Oskar Hansson, 2019 jul 19, I: Alzheimer's Research and Therapy. 11, 1, 63.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Brain myoinositol as a potential marker of amyloid-related pathology: A longitudinal study

    Olga Voevodskaya, Konstantinos Poulakis, Pia Sundgren, Danielle Van Westen, Sebastian Palmqvist, Lars Olof Wahlund, Erik Stomrud, Oskar Hansson & Eric Westman, 2019 jan 29, I: Neurology. 92, 5, s. E395-E405

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms

    Sebastian Palmqvist, Philip S. Insel, Henrik Zetterberg, Kaj Blennow, Britta Brix, Erik Stomrud, Niklas Mattsson, Oskar Hansson, Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative & The Swedish BioFINDER study The Swedish BioFINDER study, 2019, I: Alzheimer's and Dementia. 15, 2, s. 194-204

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status

    Sebastian Palmqvist, Shorena Janelidze, Erik Stomrud, Henrik Zetterberg, Johann Karl, Katharina Zink, Tobias Bittner, Niklas Mattsson, Udo Eichenlaub, Kaj Blennow & Oskar Hansson, 2019, I: JAMA Neurology. 76, 9, s. 1060-1069

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays

    Kaj Blennow, Leslie M. Shaw, Erik Stomrud, Niklas Mattsson, Jon B. Toledo, Katharina Buck, Simone Wahl, Udo Eichenlaub, Valeria Lifke, Maryline Simon, John Q. Trojanowski & Oskar Hansson, 2019, I: Scientific Reports. 9, 1, 19024.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Staging β -Amyloid Pathology with Amyloid Positron Emission Tomography

    Niklas Mattsson, Sebastian Palmqvist, Erik Stomrud, Jacob Vogel & Oskar Hansson, 2019, I: JAMA Neurology. 76, 11, s. 1319-1329 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. 2018
  36. Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease

    Niklas Mattsson, Oscar Eriksson, Olof Lindberg, Michael Schöll, Björn Lampinen, Markus Nilsson, Philip S. Insel, Ronald Lautner, Olof Strandberg, Danielle van Westen, Henrik Zetterberg, Kaj Blennow, Sebastian Palmqvist, Erik Stomrud & Oskar Hansson, 2018 nov 1, I: Neurobiology of Aging. 71, s. 81-90 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

    Oskar Hansson, John Seibyl, Erik Stomrud, Henrik Zetterberg, John Q. Trojanowski, Tobias Bittner, Valeria Lifke, Veronika Corradini, Udo Eichenlaub, Richard Batrla, Katharina Buck, Katharina Zink, Christina Rabe, Kaj Blennow, Leslie M. Shaw, Swedish BioFINDER study group Swedish BioFINDER study group & Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2018 nov, I: Alzheimer's and Dementia. 14, 11, s. 1470-1481

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Abnormal structural brain connectome in individuals with preclinical Alzheimer's disease

    Joana B. Pereira, Danielle Van Westen, Erik Stomrud, Tor Olof Strandberg, Giovanni Volpe, Eric Westman & Oskar Hansson, 2018 okt 1, I: Cerebral Cortex. 28, 10, s. 3638-3649 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease

    Shorena Janelidze, Niklas Mattsson, Erik Stomrud, Olof Lindberg, Sebastian Palmqvist, Henrik Zetterberg, Kaj Blennow & Oskar Hansson, 2018 jul 27, I: Neurology. 91, 9, s. e867-e877

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease

    Niklas Mattsson, Colin Groot, Willemijn J. Jansen, Susan M. Landau, Victor L. Villemagne, Sebastiaan Engelborghs, Mark M. Mintun, Alberto Lleo, José Luis Molinuevo, William J. Jagust, Giovanni B. Frisoni, Adrian Ivanoiu, Gaël Chételat, Catarina Resende de Oliveira, Karen M. Rodrigue, Johannes Kornhuber, Anders Wallin, Aleksandra Klimkowicz-Mrowiec, Ramesh Kandimella, Julius Popp & 75 andra, Pauline P. Aalten, Dag Aarsland, Daniel Alcolea, Ina S. Almdahl, Inês Baldeiras, Mark A. van Buchem, Enrica Cavedo, Kewei Chen, Ann D. Cohen, Stefan Förster, Juan Fortea, Kristian S. Frederiksen, Yvonne Freund-Levi, Kiran Dip Gill, Olymbia Gkatzima, Timo Grimmer, Harald Hampel, Sanna Kaisa Herukka, Peter Johannsen, Koen van Laere, Mony J. de Leon, Wolfgang Maier, Jan Marcusson, Olga Meulenbroek, Hanne M. Møllergård, John C. Morris, Barbara Mroczko, Arto Nordlund, Sudesh Prabhakar, Oliver Peters, Lorena Rami, Eloy Rodríguez-Rodríguez, Catherine M. Roe, Eckart Rüther, Isabel Santana, Johannes Schröder, Sang W. Seo, Hilkka Soininen, Luiza Spiru, Erik Stomrud, Hanne Struyfs, Charlotte E. Teunissen, Frans R.J. Verhey, Stephanie J.B. Vos, Linda J.C. van Waalwijk van Doorn, Gunhild Waldemar, Åsa K. Wallin, Jens Wiltfang, Rik Vandenberghe, David J. Brooks, Tormod Fladby, Christopher C. Rowe, Alexander Drzezga, Marcel M. Verbeek, Marie Sarazin, David A. Wolk, Adam S. Fleisher, William E. Klunk, Duk L. Na, Pascual Sánchez-Juan, Dong Young Lee, Agneta Nordberg, Magda Tsolaki, Vincent Camus, Juha O. Rinne, Anne M. Fagan, Henrik Zetterberg, Kaj Blennow, Gil D. Rabinovici, Oskar Hansson, Bart N.M. van Berckel, Wiesje M. van der Flier, Philip Scheltens, Pieter Jelle Visser & Rik Ossenkoppele, 2018 jul, I: Alzheimer's and Dementia. 14, 7, s. 913-924

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 Nästa